Mutational Analysis in Nand C-Termini of RB 1 Gene among Sporadic Retinoblastoma Patients in Malaysia

Objectives: To detect mutations and single nucleotide polymorphisms (SNPs) in Nand C-termini of RB1 and to determine the association of these genetic variations with laterality and staging of retinoblastoma in Malaysian children with RB. Methods: Peripheral blood leukocytes were collected from 66 retinoblastoma patients and 66 healthy volunteers. Tumor tissue specimen was also collected from three available patients. The DNA was extracted using commercially available extraction kit. PCR were conducted using self-designed primers. The mutational analysis was performed using DHPLC and direct sequencing. Results: Two nonsense mutations and four SNPs were detected in N-terminus, but none in C-terminus. The non-sense mutations; Arg320X and Glu323X were detected in 3 children with RB. A novel SNP; IVS1-3T > G was also identified in this study. There was a significant difference in allele frequency of IVS4-77G > A between patients and healthy control group (p = 0.044). There was no significant association between polymorphisms with laterality and staging of RB. Conclusion: Arg320X and Glu323X may play an important role in the pathogenesis of RB. SNP IVS4-77G > A is a potential genetic marker for susceptibility to RB in our population.

[1]  Arun D. Singh,et al.  Survival with retinoblastoma in the USA: 1975–2004 , 2008, British Journal of Ophthalmology.

[2]  A. Whittemore,et al.  Common variants in RB1 gene and risk of invasive ovarian cancer. , 2006, Cancer research.

[3]  G. Beauchamp,et al.  The burden of age-related macular degeneration: a value-based analysis , 2006, Current opinion in ophthalmology.

[4]  B. Ponder,et al.  Single-nucleotide polymorphisms in the RB1 gene and association with breast cancer in the British population , 2006, British Journal of Cancer.

[5]  C. Shields,et al.  Sensitive multistep clinical molecular screening of 180 unrelated individuals with retinoblastoma detects 36 novel mutations in the RB1 gene , 2005, Human mutation.

[6]  Peidong Shen,et al.  Conservation of the RB1 gene in human and primates , 2005, Human mutation.

[7]  J. Alonso,et al.  Identification of 26 new constitutional RB1 gene mutations in Spanish, Colombian, and Cuban retinoblastoma patients , 2005, Human mutation.

[8]  D. Abramson,et al.  UPDATE ON RETINOBLASTOMA , 2004, Retina.

[9]  L. Desjardins,et al.  Comprehensive screening for constitutional RB1 mutations by DHPLC and QMPSF , 2004, Human mutation.

[10]  K. Chakravarthi,et al.  Mutational screening of the RB1 gene in Indian patients with retinoblastoma reveals eight novel and several recurrent mutations , 2003, Human mutation.

[11]  Brenda Gallie,et al.  Sensitive and efficient detection of RB1 gene mutations enhances care for families with retinoblastoma. , 2003, American journal of human genetics.

[12]  K. Choy,et al.  Loss of heterozygosity and mutations are the major mechanisms of RB1 gene inactivation in Chinese with sporadic retinoblastoma , 2002, Human mutation.

[13]  H. Feiler,et al.  Retinoblastoma-related proteins in plants: homologues or orthologues of their metazoan counterparts? , 2000, Plant Molecular Biology.

[14]  B. Gallie,et al.  Retinoblastoma: the disease, gene and protein provide critical leads to understand cancer. , 2000, Seminars in cancer biology.

[15]  C. Liu,et al.  Mutations of N-terminal regions render the retinoblastoma protein insufficient for functions in development and tumor suppression , 1997, Molecular and cellular biology.

[16]  F. Prieto,et al.  Genetics of retinoblastoma: a study. , 1997, Cancer genetics and cytogenetics.

[17]  B. Horsthemke,et al.  The spectrum of RB1 germ-line mutations in hereditary retinoblastoma. , 1996, American journal of human genetics.

[18]  J. Horowitz,et al.  Detection of a Novel Cell Cycle-regulated Kinase Activity That Associates with the Amino Terminus of the Retinoblastoma Protein in G/M Phases (*) , 1995, The Journal of Biological Chemistry.

[19]  V. Blanquet,et al.  Spectrum of germline mutations in the RB1 gene: a study of 232 patients with hereditary and non hereditary retinoblastoma. , 1995, Human molecular genetics.

[20]  A. Hogg,et al.  Molecular mechanisms of oncogenic mutations in tumors from patients with bilateral and unilateral retinoblastoma. , 1993, Proceedings of the National Academy of Sciences of the United States of America.

[21]  T. Dryja,et al.  Detection of DNA sequence polymorphisms by enzymatic amplification and direct genomic sequencing. , 1989, American journal of human genetics.

[22]  W. Lee,et al.  Inactivation of the retinoblastoma susceptibility gene in human breast cancers. , 1988, Science.

[23]  D. Abramson,et al.  Current Management Strategies for Intraocular Retinoblastoma , 2012, Drugs.

[24]  C. Shields,et al.  The International Classification of Retinoblastoma predicts chemoreduction success. , 2006, Ophthalmology.

[25]  J. Cowell,et al.  Frequent Constitutional C to T Mutations in CGA-Arginine Codons in the RB1 Gene Produce Premature Stop Codons in Patients with Bilateral (Hereditary) Retinoblastoma , 1994, European journal of human genetics : EJHG.